Bacillus Calmette-Guérin Therapy Optimizing Outcomes amid Challenges

Overview of attention for article published in Urologic Clinics of North America, April 2026

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter: 4 X users

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,260 followers.

RT @UIowa_urology: New from Drs. @HougenHY, Michael A. O’Donnell, and Tutku E. Tazegul in Urologic Clinics of North America: Bacillus Calme…

This was so fun to write. BCG is an old drug but it remains dynamic--I received a draft to review in 2 weeks was already outdated because POTOMAC and ALBAN read out. This was a 💪 lift by Dr Tazegul and as always 🙏 to #MOD for his vast experience and adv…

RT @UIowa_urology: New from Drs. @HougenHY, Michael A. O’Donnell, and Tutku E. Tazegul in Urologic Clinics of North America: Bacillus Calme…

New from Drs. @HougenHY, Michael A. O’Donnell, and Tutku E. Tazegul in Urologic Clinics of North America: Bacillus Calmette-Guérin Therapy: Optimizing Outcomes amid Challenges. https://t.co/Ont0rOT5rx https://t.co/QSSJrs7tWy

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.